Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 62Glioblastoma 52Lung Neoplasms 49Breast Neoplasms 46Prostatic Neoplasms 39Head and Neck Neoplasms 38Squamous Cell Carcinoma of Head and Neck 33Esophageal Neoplasms 30Brain Neoplasms 28Lymphoma 27Gliosarcoma 27Rectal Neoplasms 24Hodgkin Disease 24Pancreatic Neoplasms 22Adenocarcinoma Of Esophagus 22Central Nervous System Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Neoplasms 20Lymphoma, Non-Hodgkin 17Leukemia 17Glioma 17Burkitt Lymphoma 16Sarcoma 15Lymphoma, Large B-Cell, Diffuse 15Lymphoma, Follicular 14Carcinoma, Squamous Cell 14Colorectal Neoplasms 13Astrocytoma 13Neoplasm Metastasis 12Melanoma 12

Interventions

Rituximab 40Cyclophosphamide 29Etoposide 15Doxorubicin 14Vincristine 13Prednisone 13ibrutinib 10fludarabine 10fludarabine phosphate 8Cytarabine 8Mycophenolic Acid 7Bortezomib 7Lenalidomide 6Carmustine 6pembrolizumab 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Inotuzumab Ozogamicin 5Whole-Body Irradiation 4Tacrolimus 4Carboplatin 4CT-P10 4Brentuximab Vedotin 4Antilymphocyte Serum 4tositumomab I-131 3tocilizumab 3tazemetostat 3obinutuzumab 3idelalisib 3etoposide phosphate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, B-Cell × Radiotherapy × Clear all
NCT02266147 2020-09-04

Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma

Dynavax Technologies Corporation

Phase 1/2 Terminated
29 enrolled 16 charts
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡